Human Organoids Market Segmentation:
Product Segment Analysis
The kidney segment is estimated to gain the largest human organoids market share over the projected time frame attributed to the increasing number of kidney transplants performed globally as compared to other procedures. According to the American Kidney Fund, currently, there are more than 92,000 people on the national transplant list waiting for a kidney. Moreover, there has been a significant growth in kidney-related diseases which is projected to contribute to the segment growth. National Kidney Foundation states that currently 10% of the population globally is affected by chronic kidney disease. Organoid transplantation promotes the formation of target mesangial and pericyte cells in kidney organoids.
End-user Segment Analysis
The biotech & pharma industry segment in human organoids market is expected to garner a significant share on the back of rising focus on developing new drugs. In 2022, the Center for Drug Evaluation and Research approved 37 novel drugs as new therapeutic biological products. Organoids are replicated from the patient's tissue that simulate the response to radiation therapy and have the potential to act as biomarkers. Organoids have garnered remarkable attention in drug discovery due to their potential to revolutionize the drug development process.
Our in-depth analysis of the global human organoids market includes the following segments:
|
Product |
|
|
End user |
|
